Catalepsy induced by intra-striatal administration of nitric oxide synthase inhibitors in rats
Introduction
Nitric oxide (NO) is a short-lived, highly liposoluble molecule, produced from the amino acid l-arginine by a family of enzymes called NO synthases (NOS; Moncada and Higgs, 1993). It acts as a signalling molecule in the central nervous system and has been related to several physiological or pathological conditions (for review, see Bredt, 1999, Esplugues, 2002).
NO seems to play a role in the control of motor behaviour. Mice mutant for the neuronal NOS isoform have altered locomotor abilities (Kriegsfeld et al., 1999) and rats and mice treated with various NOS inhibitors show problems with fine motor control Star and Star, 1995, Dzoljic et al., 1997, Araki et al., 2001, Uzbay, 2001, Dall'Igna et al., 2001, Del Bel et al., 2002. Systemic administration of NG-nitro-l-arginine (l-NOARG), an inhibitor of NOS, induces catalepsy in mice Marras et al., 1995, Navarro et al., 1997, Cavas and Navarro, 2002, Del Bel et al., 2002. This effect is attenuated by previous treatment with l-arginine and suffers tolerance after four days of subchronic (twice a day, 4 days) administration Marras et al., 1995, Navarro et al., 1997.
The cataleptic effect of NOS inhibitors may involve the striatum. NOS positive neurons are located throughout this structure (Vincent and Kimura, 1992) and NO is proposed to regulate dopamine neurotransmission in the striatum (West et al., 2002). Although there are contradictory results (Silva et al., 1995) most studies suggest that, under physiological conditions, NO increases striatal dopamine by facilitating its release Hanbauer et al., 1992, Black et al., 1994, Stewart et al., 1996, West and Galloway, 1998, Iravani et al., 1998, West et al., 2002 and/or by decreasing its reuptake Guevara-Guzman et al., 1994, Kiss and Vizi, 2001. However, the possible participation of the striatum on the cataleptic effects of NOS inhibition has not yet been directly tested nor has the presence of these effects in other rodent species such as the rat.
The objective of the present study, therefore, was to verify if NOS inhibition can also induce catalepsy in rats and if this effect involves inhibition of NO formation in the central nervous system, particularly in the striatum.
Section snippets
Animals
Male Albino Wistar rats (200–250 g) were housed in groups of five or eight per cage in a temperature-controlled room (24±1 °C) under standard laboratory conditions. They had free access to food and water and remained on a 12 h light/12 h dark cycle (lights on at 06:30 a.m.). Procedures were conducted in conformity with the Brazilian Society of Neuroscience and Behaviour guidelines for the care and use of laboratory animals, which are in compliance with international laws and politics. All
Experiment 1
Results are in Fig. 1. There were significant general effects of treatment (F(3,40)=57.47, P<0.001), time (F(2,39)=13.96, P<0.001) and treatment×time (F(6,76)=3.04, P=0.01). All doses of l-NOARG increased catalepsy time along the whole experiment as compared to saline group (Duncan test, P<0.05). The dose of 160 mg/kg, in addition, produced greater catalepsy than the 40 and 80 mg/kg doses 2 and 4 h after injection (Duncan, P<0.05).
Experiment 2
All doses of l-NAME and l-NOARG increased catalepsy time
Discussion
Catalepsy is defined as a failure to correct an externally imposed posture. Drugs that decrease dopaminergic neurotransmission in the striatum, such as neuroleptics, induce catalepsy in rodents and Parkinson symptoms in humans Koffer et al., 1978, Sanberg et al., 1988. This test is widely used to evaluate motor effects of drugs that act on the extrapyramidal system Sanberg et al., 1988, Hauber, 1998.
Similar to previous results obtained in mice Marras et al., 1995, Del Bel and Guimarães, 2000,
Acknowledgments
Research supported by grants from FAPESP, CAPES and CNPq. The authors are recipients of CNPq fellowships.
References (53)
- et al.
Effect of NO synthase inhibition on behavioral changes induced by a single administration of methamphetamine
Brain Res.
(1994) - et al.
Nitric oxide synthase inhibitors cause motor deficits in mice
Eur. Neuropsychopharmacol.
(2001) - et al.
The effects of a photosensitive nitric oxide donor on basal and electrically-stimulated dopamine efflux from direct striatum in vitro
Neuropharmacology
(1994) - et al.
Nitric oxide regulation of methamphetamine-induced dopamine release in caudate/putamen
Brain Res.
(1995) - et al.
Synaptic plasticity and physiological interactions between dopamine and glutamate in the striatum
Neurosci. Biobehav. Rev.
(1997) - et al.
Coadministration of l-NOARG and tiapride: effects on catalepsy in male mice
Prog. Neuro-Psychopharmacol. Biol. Psychiatry
(2002) Roles of NMDA receptor activity and nitric oxide production in brain development
Brains Res. Rev.
(2000)- et al.
Catalepsy and hypolocomotion induced by nitric oxide donor: attenuation by theophyline
Eur. J. Pharmacol.
(2001) - et al.
Catalepsy induced by nitric oxide inhibitors
Gen. Pharmacol.
(1998) Glutamate, nitric oxide and cell-signalling in the nervous system
TINS
(1991)
Distribution of Nω-nitro-l-arginine following topical and intracerebroventricular administration in the rat
Neurosci. Lett.
Involvement of basal ganglia transmitter systems in movement initiation
Prog. Neurobiol.
Endothelial cells metabolize NG-monomethyl-l-arginine to l-citrulline and subsequently to l-arginine
Biochem. Biophys. Res. Commun.
Nitric oxide modulates NMDA-induced increases in intracellular Ca2+ in cultured rat forebrain neurons
Brain Res.
Nitric oxide: a novel link between synaptic and nonsynaptic transmission
TINS
The role of the corpus striatum in neuroleptic- and narcotic-induced catalepsy
Eur. J. Pharmacol.
Nocturnal motor coordination deficits in neuronal nitric oxide synthase knock-out mice
Neuroscience
Modulation of stress-induced neurobehavioral changes by nitric oxide in rats
Eur. J. Pharmacol.
NMDA receptor antagonists inhibit catalepsy induced by either dopamine D1 or D2 receptor antagonists
Eur. J. Pharmacol.
Serotonin modulation of catalepsy induced by NG-nitro-l-arginine in mice
Eur. J. Pharmacol.
Determination of brain nitric oxide synthase inhibition in vivo: ex vivo assays of nitric oxide synthase can give incorrect results
Neuropharmacology
Role of nitric oxide in modulating neurotransmitter release from rat striatum
Brain Res. Bull.
Inhibition of nitric oxide synthase influences the activity of striatal neurons in the rat
Neurosci. Lett.
l-NAME precipitates catatonia during ethanol withdrawal in rats
Behav. Brain Res.
Histochemical mapping of nitric oxide synthase in the rat brain
Neuroscience
Nitric oxide and potassium chloride-facilitate striatal dopamine efflux in vivo: role of calcium dependent release mechanisms
Neurochem. Int.
Cited by (43)
Nitric Oxide Signaling in the Striatum
2016, Handbook of Behavioral NeuroscienceCitation Excerpt :A variety of psychopharmacological studies performed in behaving rodents indicate that striatal nNOS interneurons play a critical role in the generation of motor behavior (Del Bel et al., 2011, 2005; Lorenc-Koci and Czarnecka, 2013). Thus, systemic and intrastriatal administration of NOS and sGC inhibitors has been reported to suppress basal locomotion and promote catalepsy (Del Bel et al., 2004; Echeverry et al., 2007; Stewart et al., 1994). Disruption of nNOS function also potentiates catalepsy induced via D2-like receptor antagonist administration (Cavas and Navarro, 2002; Del Bel and Guimaraes, 2000).
The preferential nNOS inhibitor 7-nitroindazole and the non-selective one N<sup>G</sup>-nitro-l-arginine methyl ester administered alone or jointly with l-DOPA differentially affect motor behavior and monoamine metabolism in sham-operated and 6-OHDA-lesioned rats
2015, Brain ResearchCitation Excerpt :This test is widely used to evaluate motor effect of drugs, especially those related to the extrapyramidal system (Sanberg et al., 1984; Hauber, 1998). The cataleptogenic effects of 7-NI and l-NAME observed by us in unilaterally sham-operated and 6-OHDA-lesioned rats are consistent with the previous studies performed in naïve rats both after their systemic (Araki et al., 2001; Del Bel et al., 2002) or intrastriatal administration (Del Bel et al., 2004). The mechanisms which are responsible for an impairment of motor behavior under conditions of NO deficiency have not been elucidated so far.
Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease
2015, Progress in NeurobiologyGlutamatergic neurotransmission in the inferior colliculus influences intrastriatal haloperidol-induced catalepsy
2014, Behavioural Brain Research